Friday, September 23rd
10:45am-12:15pm EDT


Topical Workshop


Specific Pain Conditions/Pain in Specific Populations


713 A

Cognitive Behavioral Therapy for Suicide Prevention

Individuals with substance use disorders, including opioid-related problems, are at clear elevated risk for suicide. However, little is known about how to reduce suicide risk in these individuals. This presentation will review results of a study that examine the specific components of Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) delivered as part of a large, ongoing clinical trial. 

Methods: Materials will be presented from a multi-site randomized control trial (n=300) evaluating CBT-SP in Veterans with substance-related problems. Following each session and at the end of the treatment, patients provided feedback regarding their session experiences.
Results: Of the patients randomized to the CBT-SP, 69.3 % completed all 8 therapy sessions. Patients who completed fewer than 8 sessions were significantly more likely to be of younger age, have prior combat experience, and report more intense suicidal ideation over the past month (p< 0.01) Overall, patients responded positively to the CBT-SP treatment, with 70.8% reporting improvement in their mood immediately following the session.
Conclusions: Patients assigned to receive CBT-SP reported active engagement and positive experiences, suggesting CBT-SP was well-received among these Veterans. Exploring patient feedback is essential in understanding the effective components of CBT-SP and what helps patients engage in treatment.


Dr. Mark Ilgen

University of Michigan